Telomeres Might Predict Lung Cancer Recurrence
Telomeres are sections of DNA that tell an interesting story about lifespan. Shorter telomeres usually suggest a shorter life -- but new research by a Wilmot lung cancer expert shows that longer telomeres might be a promising biomarker for a recurrence of early stage lung cancer.
Why do we sleep? It is a question that has long puzzled scientists and philosophers alike. While the ancient Greeks saw sleep as a doorway to the divine, scientists and biologists see it as an invitation to be devoured by nocturnal predators. A new study – appearing today in the journal Science – may provide the answer: when we sleep our brain ‘takes out the trash.’
10/17/2013 | 6 comments
Scientists are scrambling to gather data for the FDA to support the need for a blood test to diagnose brain injury in the United States. The University of Rochester Medical Center just added significant evidence by reporting in the Journal of Neurotrauma that it might be clinically useful to measure two brain biomarkers instead of one.
10/15/2013 | 0 comments
First, the good news: The survival rate for testicular cancer is 95 percent at 10 years, due to the invention of cisplatin-based chemotherapy in the 1970s. Despite this success, however, survivors have an increasing risk of second malignancies -- and the risk remains elevated for 35 years.
10/9/2013 | 0 comments
A new vaccine for norovirus – the microbe behind most cases of what people commonly call stomach flu – protected patients against severe vomiting and diarrhea. URMC was one of five study sites that enrolled patients and tested the experimental vaccine.
10/8/2013 | 1 comment
Those fascinating creatures are in the news again. In a study published in June researchers found a key to their cancer resistance. This week, University of Rochester biologists showed that the rodent’s longevity – they live a healthy 30 years, which is very long in rat years – is due to better-constructed proteins.
10/1/2013 | 0 comments